A director's trust sells 10,000 shares under a trading plan at Corcept Therapeutics (CORT).
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
James N. Wilson, a director at Corcept Therapeutics Inc. (CORT), reported that his trust sold a total of 10,000 common shares on October 15, 2026, under a Rule 10b5-1 trading plan established on March 12, 2026. The shares were sold in three transactions at weighted average prices ranging from Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context